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Mesenteric, hepatic and splanchnic extraction of 
C-terminal and N-terminal atrial natriuretic factor 
was investigated in male Sprague-Dawley rats. Plasma 
concentrations (mean f S.E.M.) of C-terminal atrial 
natriuretic factor were 55.0 f 6.1 fmouml, 31.2 f 4.0 
fmoUml and 23.5 f 3.3 fmol/ml (n = 12) in the ab- 
dominal aorta, the portal vein and the hepatic vein, 
respectively. N-terminal atrial natriuretic factor 
plasma levels in these vessels were 3031 * 766 fmoUml, 
2264 f 661 fmoUml and 1618 f 496 fmol/ml (n = 61, 
respectively. Although the mesenteric extraction ratio 
was higher (p < 0.05) for C-terminal atrial natriuretic 
factor (42% f 6%) than for N-terminal atrial natri- 
uretic factor (28% f 4%), there were no significant 
differences in the hepatic extraction ratio (41% f 6% 
vs. 39% f 6%) and the splanchnic extraction ratio 
(56% k 5% vs. 50% f 7%). These data suggest a major 
role of the liver in the splanchnic extraction of 
C-terminal and of N-terminal atrial natriuretic factor 
in the rat. (HEPA"KOGY 1992;16790-793.) 
The atrial natriuretic factor (ANF) has been shown to 
be involved in volume homeostasis (1-7). Furthermore, 
there is increasing evidence that it may play a role in 
immune and reproductive functions (8, 9). ANF circu- 
lates as a 28-amino acid C-terminal fragment and a 
98-amino acid N-terminal fragment. Although the 
C-terminal fragment is known to be the bioactive 
compound of ANF, the biological role of the N-terminal 
is not yet clearly established. However, there is evidence 
of a vasodilatory effect of this fragment after further 
cleavage in plasma (10). 
As yet, there is limited knowledge of the clearance of 
ANF from the circulation because there are only a few 
studies on the extraction ratios of C-terminal ANF by 
various organs and there is virtually no information on 
Received January 10, 1992; accepted May 1, 1992. 
This study was supported by the Deutsche Forschungsgemeinschaft (Ge 
576/2-2) and by an Asche Stipendium to A. L. Gerbes. This work contains data 
from a doctoral thesis by R. Witthaut and V. Gulberg at the Ludwig-Maximilians 
University, Munich, Germany. 
Address reprint requests to: Alexander L. Gerbes, M.D., Medizinische Klinik 
11, Klinikum Grosshadern, Universitiit Miinchen, Marchioninistrasee 15, 8000 
Munich 70, Germany 
31/1/39?366 
the clearance of the N-terminal fragment (1 1). In human 
beings and dogs, a significant extraction of ANF by the 
lungs, the kidney, the peripheral circulation and the 
splanchnic circulation has been shown (12). So far no 
information exists on the role of the liver in the 
splanchnic extraction of ANF. Although one study uses 
ANF infusion (131, no data are available on ANF 
extraction under basal conditions in the rat (14). 
However, these may be questions of considerable in- 
terest because there is conflicting information on ANF 
plasma concentrations in liver disease (7, 15-17). 
Therefore, to characterize the extraction of circulating 
ANF in more detail, we investigated the role of the 
liver in extraction of C-terminal and N-terminal ANF 
in rats. 
MATERIALS AND METHODS 
Animals. Male Sprague-Dawley rats weighing 280 gm to 
330 gm and kept under standardized conditions were anesthe- 
tized with sodium pentobarbital intraperitoneally (60 mg/kg), 
heparinized with 250 IU intravenously and then laparot- 
omized. Multiple blood sampling was carried out by direct 
vessel puncture (abdominal aorta and portal vein) or by venous 
catheterization with a 20-gauge Teflon cannula (hepatic vein). 
Blood was immediately transferred into precooled tubes 
containing EDTA (1 mg/ml), centrifuged at 1500 gm and stored 
at - 70" C until assay. 
RIA for ANF. C-terminal ANF (99 to 126) was determined 
in the extract of 100 ~1 plasma by use of antibody Toni I11 (18, 
191, as published previously. Intraassay and interassay varia- 
tions were below 10% and 15%, respectively; recoveries 
averaged 70%. The RIA for the N-terminal fragment of 
pro-ANF was performed with 50 ~1 plasma and antibody GT 23 
as described elsewhere in detail (20). The intraassay and 
interassay coefficients of variation were less than 12%, and 
recoveries were close to 100%. 
Cakulationa and Statieticml Evaluation. Extraction ratios 
in percentages for C-terminal and N-terminal ANF were 
calculated by the following formulas: Splanchnic extrac- 
tion = ([C, - C,I/Ca) x 100 (%), Mesenteric extraction = 
([C, - C l/Ca) x 100 (%) and Hepatic extraction = ([Y3C, + 
%Ca - &/[Y3C + %CJ) x 100 (%), where C = concen- 
tration, a = abdPominal aorta,p = portal vein and h = hepatic 
vein. These formulas are based on the finding that blood flow 
through the portal vein is twice the hepatic arterial blood flow 
(21). Concentration gradients in ferntomoles per milliliter were 
calculated accordingly. For these calculations values from 
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FIG. 1. Plasma concentrations of C-terminal ANF in abdominal aorta, portal vein and hepatic vein of rats. Lines connect the values obtained 
in the Same animals. 
different vascular regions of the same animal (paired samples) 
were used. 
Differences between means were compared by paired and 
unpaired t tests where appropriate. A p value of less than 0.05 
was considered statistically significant. Data are presented as 
mean and S.E. 
RESULTS 
The plasma concentrations of C-terminal ANF in the 
hepatic vein (23.5 f 3.3 fmol/ml) were significantly 
lower (p < 0.001) than in the abdominal aorta 
(55.0 f 6.1 fmoVml; n = 12) (Fig. 11, corresponding to 
a splanchnic extraction ratio of 56% * 5% (Table 1). 
Mesenteric ANF extraction rate was lower (42% f 6%) 
(Table 11, with concentrations of C-terminal ANF in the 
portal vein of 31.2 2 4.0 fmoVml and in the abdominal 
aortaof55.0 2 G.lfmoVml(n = 12;p < O.OOl).Plasma 
concentrations in the hepatic vein (23.5 ? 3.3 fmoVml) 
were significantly lower (p < 0.001) than in the portal 
vein (31.2 k 4.0 fmoVml; n = 12) (Fig. 1). Taking into 
account the arterial part of liver perfusion, we found 
that 41% f 5% of C-terminal ANF was eliminated by 
the liver. This figure was not significantly different from 
the mesenteric extraction rate of 42% 2 6% (Table 1). 
Splanchnic extraction of N-terminal ANF averaged 
50% 2 7% (Table 11, with concentrations of the 
N-terminal fragment of 3,031 2 756 fmoVml in the 
aorta and 1,618 2 496 fmoVml in the hepatic vein 
(p < 0.005; n = 6). Mesenteric extraction of the 
N-terminal ANF was significantly lower than that of the 
C-terminal ANF (28% f 4% vs. 42% f 6%; p < 0.011, 
with concentrations of 2,264 k 661 fmoVml in the 
portal vein and 3,031 5 756 fmoVml in the aorta 
(p < 0.001; n = 6). The concentration of N-terminal 
ANF was 1,618 f 496 fmoVml in the hepatic vein as 
opposed to 2,264 k 661 fmoVml in the portal vein 
(p < 0.05; n = 6) (Fig. 2), resulting in hepatic extrac- 
tion of 39% f 6% (Table 1). Hepatic extraction of 
N-terminal ANF was significantly higher (39% k 6%) 
than mesenteric extraction (28% * 4%; p < 0.05). 
DISCUSSION 
This study provides new results on the role of the liver 
in splanchnic ANF extraction and the splanchnic ex- 
traction of N-terminal ANF. The splanchnic extraction 
rate of C-terminal ANF in rats was found to be 56%. This 
rate is well in the range reported for the intestinal ANF 
extraction in human beings (28% to 71%) (12,17,22-27) 
and somewhat higher than the 28% to 36% reported in 
dogs (12,28). The role of the liver in the splanchnic ANF 
extraction has not been established so far. However, 
there is evidence that in liver failure the clearance of 
ANF is reduced (29). Furthermore, a significant uptake 
of iodinated ANF from the circulation by the liver 
suggests a role of this organ in ANF clearance (30). 
Recently, Hollister et al. (12) observed a concentration 
difference corresponding to 16% of C-terminal ANF 
between portal and hepatic veins in dogs. In view of the 
much higher concentration of ANF in arterial blood and 
the fact that hepatic arterial blood flow constitutes about 
one third of total hepatic blood flow (211, this would 
indicate a hepatic ANF extraction of about 44% -very 
close to the 41% that we found in the rat. In our study 
the rate of hepatic extraction of C-terminal ANF 
(41% 2 5%) was similar to the mesenteric extraction 
rate (42% ? 6%). 
As yet, there are no data available on extraction of the 
N-terminal ANF fragment. Our data show that 
N-terminal ANF is extracted in the splanchnic circu- 
lation and that the liver is more important in this regard 
than the mesenteric circulation (39% ? 6% vs. 
28% +- 4% extraction; p < 0.05). Thus although the 
hepatic extraction ratio of C-terminal and N-terminal 
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FIG. 2. Plasma concentrations of N-terminal ANF in abdominal aorta, portal vein and hepatic vein of rats. Lines connect the values obtained 
in the same animals. 
TABLE 1. Extraction of ANF in rats 
c-terminal ANF- N-terminal ANFb 
gradient (fmoUml) Extraction (%) gradient (fmoUml) Extraction (%) 
Concentration Concentration 
Mesenteric extraction 23.8 5 5.4cad 41.6 ? 5.8d 766 f 130d,"f 28.3 f 4.1""f 
39.1 f 6.1d Hepatic extraction 15.6 ? 2.v 40.8 ? 4.Sd 
Splanchnic extraction 31.5 f 1.9f 56.2 ? 5.0f 1412 f 295'rf 49.9 f 6.5, 
901 f 217"re 
"n = 12. 
bn = 6. 
=Data expressed as mean f S.E.M. 
dp < 0.05 vs. splanchnic extraction. 
ep c 0.05 vs. corresponding C-terminal values. 
fp < 0.05 vs. hepatic extraction. 
ANF fragments by the liver is similar, the mesenteric 
extraction of C-terminal ANF is greater than that of the 
N-terminal fragment. It has been shown that clearance 
of the C-terminal ANF is caused by three mechanisms. 
The first mechanism is the binding of ANF to the 
C-receptor, subsequent internalization and rapid degra- 
dation in lysosomes. The second is the enzymatic 
degradation by endopeptidase 24.11 (11) and by a 
carboxypeptidase (31,32). The third mechanism, which 
is rather unspecific, is glomerular filtration and renal 
excretion. Endopeptidase 24.11 activity has been dem- 
onstrated mainly in the kidney, but recently also in the 
mesentric artery of the rat by ex uzuo perfusion and 
membrane preparation techniques (33). Presence of the 
C-receptor has been shown in various organs including 
the liver (34). There are no data as yet on the 
mechanisms of clearance of the N-terminal ANF 
fragment. Altogether our data suggest a major role of the 
liver in the splanchnic extraction of C-terminal and 
N-terminal ANF in the rat. 
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